gefitinib has been researched along with Fibrosarcoma in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Gallez, B; Grégoire, V; Jordan, BF; Karroum, O; Kengen, J | 1 |
Ando, K; Hatori, A; Kawamura, K; Koike, S; Kumata, K; Suzuki, K; Takai, N; Toyohara, J; Yamasaki, T; Yanamoto, K; Yui, J; Zhang, MR | 1 |
2 other study(ies) available for gefitinib and Fibrosarcoma
Article | Year |
---|---|
Tumor reoxygenation following administration of the EGFR inhibitor, gefitinib, in experimental tumors.
Topics: Animals; Cell Hypoxia; Electron Spin Resonance Spectroscopy; ErbB Receptors; Fibrosarcoma; Gefitinib; Liver Neoplasms, Experimental; Mice; Mice, Inbred C3H; Oximetry; Oxygen; Oxygen Consumption; Quinazolines | 2013 |
[11C]Gefitinib ([11c]Iressa): radiosynthesis, in vitro uptake, and in vivo imaging of intact murine fibrosarcoma.
Topics: Animals; Carbon Radioisotopes; Cell Line, Tumor; Fibrosarcoma; Gefitinib; Humans; Male; Mice; Molecular Imaging; Positron-Emission Tomography; Quinazolines; Tissue Distribution | 2010 |